Inetetamab combined with pyrotinib and oral vinorelbine for patients with human epidermal growth factor receptor 2 positive advanced breast cancer: A single-arm phase 2 clinical trial

Nan Jin,Yi Xu,Siqi Wang,Chunxiao Sun,Xueqi Yan,Fan Yang,Yan Liang, Weiwei Chen,Xiang Huang

Cancer Pathogenesis and Therapy（2024）

引用 0|浏览7

暂无评分

摘要

CI: Confidence interval; DCR: Disease control rate; ECOG PS: Eastern Cooperative Oncology Group performance status; FISH: Fluorescence in situ hybridization; HER2: Human epidermal growth factor receptor 2; IHC: Immunohistochemistry; mPFS: Median progression-free survival; QD: Quaque die; QW: Quaque week; ORR: Objective response rate; OS: Overall survival; RECIST: Response Evaluation Criteria in Solid Tumors.Image 1

查看译文

关键词

positive advanced breast cancer,epidermal growth factor,breast cancer,oral vinorelbine,single-arm

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要